ACM
EDIT icon

Aquatic Capital Management’s Editas Medicine EDIT Stock Holding History

Aquatic Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,500
Closed -$122K – 1332
2024
Q1 		$122K Buy
+16,500
New +$137K ﹤0.01% 871
2023
Q2 		– Sell
-7,700
Closed -$56K – 1444
2023
Q1 		$56K Buy
7,700
+6,000
+353% +$53.3K ﹤0.01% 869
2022
Q4 		$15K Sell
1,700
-16,800
-91% -$184K ﹤0.01% 1183
2022
Q3 		$226K Buy
18,500
+12,900
+230% +$201K 0.02% 587
2022
Q2 		$66K Buy
5,600
+3,900
+229% +$52.3K 0.02% 585
2022
Q1 		$32K Buy
+1,700
New +$31.6K 0.05% 379

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Aquatic Capital Management's EDIT Position: Q2 2024 in Review

Aquatic Capital Management sold out of Editas Medicine (EDIT) in Q2 2024, closing a stake of 16,500 shares — an estimated $122K sold.

Aquatic Capital Management first reported a position in EDIT in Q1 2022 and held it in 6 quarters. The position peaked at $226K in Q3 2022. 235 funds tracked by Wall St. Rank hold EDIT as of Q2 2024.

  • Aquatic Capital Management reported no remaining Editas Medicine position as of Q2 2024 after selling out during the quarter.
  • Aquatic Capital Management sold 16,500 Editas Medicine shares in Q2 2024, an estimated $122K.
  • Aquatic Capital Management first reported a position in Editas Medicine in Q1 2022 and held it in 6 quarters.
  • Aquatic Capital Management's Editas Medicine position peaked at $226K in Q3 2022.
  • 235 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2024.

Based on Aquatic Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.